Litcius/Paper detail

PD-L1: Can it be a biomarker for the prognosis or a promising therapeutic target in cervical cancer?

Ruizhe Wang, Yi Zhang, Fengping Shan

2021International Immunopharmacology10 citationsDOI

Topics & Concepts

MedicineCervical cancerImmunotherapyOncologyCancerChemoradiotherapyDiseaseInternal medicineClinical trialBiomarkerBiochemistryChemistryCancer Immunotherapy and BiomarkersColorectal and Anal CarcinomasImmunotherapy and Immune Responses
PD-L1: Can it be a biomarker for the prognosis or a promising therapeutic target in cervical cancer? | Litcius